Carrie A Redlich Selected Research

1,6-hexamethylene diisocyanate (hexamethylene diisocyanate)

1/2018	Polymerization of hexamethylene diisocyanate in solution and a 260.23 m/z [M+H]+ ion in exposed human cells.
5/2003	Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carrie A Redlich Research Topics

Disease

26	Asthma (Bronchial Asthma) 01/2022 - 05/2002
14	Occupational Asthma 09/2022 - 02/2002
6	Infections 01/2022 - 01/2021
3	Contact Dermatitis (Eczema, Contact) 09/2022 - 07/2005
3	COVID-19 01/2022 - 01/2021
3	Eosinophilia 01/2020 - 05/2002
3	Pneumonia (Pneumonitis) 01/2019 - 05/2002
3	Neoplasms (Cancer) 01/2015 - 01/2003
3	Inflammation (Inflammations) 03/2011 - 05/2002
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 09/2022 - 01/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019 - 04/2015
2	Lung Diseases (Lung Disease) 04/2015 - 04/2008
2	Asbestosis 11/2005 - 02/2005
2	Lung Neoplasms (Lung Cancer) 11/2005 - 02/2005
1	Tuberculosis (Tuberculoses) 01/2019
1	Sarcoidosis (Schaumann Disease) 01/2019
1	Pulmonary Alveolar Proteinosis 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Chronic Bronchitis 01/2019
1	Silicosis 12/2018
1	Neoplasm Metastasis (Metastasis) 10/2011
1	Vitamin A Deficiency 10/2011
1	Lung Injury 10/2011
1	Wounds and Injuries (Trauma) 05/2010
1	Berylliosis 04/2008
1	Colorectal Neoplasms (Colorectal Cancer) 11/2005
1	Dementia (Dementias) 06/2005

Drug/Important Bio-Agent (IBA)

16	IsocyanatesIBA 09/2022 - 09/2003
7	Polyurethanes (Polyurethane)IBA 01/2012 - 02/2002
6	Immunoglobulin G (IgG)IBA 01/2021 - 03/2011
5	4,4'-diphenylmethane diisocyanate (methylene diphenyl diisocyanate)IBA 01/2022 - 05/2010
4	AntigensIBA 01/2021 - 05/2002
3	VaccinesIBA 01/2022 - 01/2021
3	Immunoglobulin E (IgE)IBA 01/2020 - 10/2006
3	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 12/2017 - 10/2006
3	Vitamin A (Retinol)FDA LinkGeneric 10/2011 - 02/2005
3	AlbuminsIBA 03/2011 - 06/2004
2	SARS-CoV-2 spike proteinIBA 01/2022 - 01/2021
2	AllergensIBA 01/2022 - 05/2010
2	EnzymesIBA 01/2022 - 03/2011
2	mRNA VaccinesIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
2	AntibodiesIBA 01/2021 - 01/2021
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 05/2018 - 05/2010
2	1,6-hexamethylene diisocyanate (hexamethylene diisocyanate)IBA 01/2018 - 05/2003
2	AsbestosIBA 11/2005 - 02/2005
2	beta Carotene (Betacarotene)FDA Link 11/2005 - 02/2005
2	CarcinogensIBA 02/2005 - 01/2003
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	EpitopesIBA 01/2021
1	ChemokinesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Peptides (Polypeptides)IBA 05/2018
1	MineralsIBA 04/2015
1	2- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA 03/2011
1	Filaggrin ProteinsIBA 05/2010
1	Irritants (Vesicants)IBA 09/2008
1	Carrier Proteins (Binding Protein)IBA 10/2006
1	VitaminsIBA 02/2005
1	CytokinesIBA 05/2002

Therapy/Procedure

2	Mechanical Ventilators (Ventilator) 10/2012 - 06/2012
2	Chemoprevention 11/2005 - 02/2005
1	Therapeutics 01/2021
1	Personal Protective Equipment 10/2012
1	Critical Care (Surgical Intensive Care) 06/2005
1	Home Nursing (Nursing, Home) 06/2005
1	Secondary Prevention 01/2003